Evidence map›Paper›PMID 36358491›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Serum Bilirubin and Markers of Oxidative Stress and Inflammation in a Healthy Population and in Patients with Various Forms of Atherosclerosis.

Libor Vítek, Alena Jirásková, Ivana Malíková, Gabriela Dostálová, Lenka Eremiášová, Vilém Danzig, Aleš Linhart, Martin Haluzík

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Libor VítekInstitute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Kateřinská 32, 121 08 Prague, Czech Republic.ORCID 0000-0002-5318-0151
Alena JiráskováInstitute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Kateřinská 32, 121 08 Prague, Czech Republic.
Ivana MalíkováInstitute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Kateřinská 32, 121 08 Prague, Czech Republic.
Gabriela Dostálová2nd Department of Internal Medicine, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, U. Nemocnice 2, 128 08 Prague, Czech Republic.ORCID 0000-0003-4809-1274
Lenka Eremiášová2nd Department of Internal Medicine, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, U. Nemocnice 2, 128 08 Prague, Czech Republic.
Vilém Danzig2nd Department of Internal Medicine, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, U. Nemocnice 2, 128 08 Prague, Czech Republic.
Aleš Linhart2nd Department of Internal Medicine, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, U. Nemocnice 2, 128 08 Prague, Czech Republic.
Martin HaluzíkInstitute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Kateřinská 32, 121 08 Prague, Czech Republic.
Charles University · CZ

Funding

Charles University Cooperatio Program, research area DIAG,Ministry of Education Youth and Sports NPO EXCELES CarDia LX22NPO5104Ministry of Health MH CZ-DRO-VFN64165
6 · The paper itself

Abstract

Oxidative stress and inflammation contribute significantly to atherogenesis. We and others have demonstrated that mildly elevated serum bilirubin levels protect against coronary and peripheral atherosclerosis, most likely due to the antioxidant and anti-inflammatory activities of bilirubin. The aim of the present study was to assess serum bilirubin and the markers of oxidative stress and inflammation in both healthy subjects and patients with various forms of atherosclerosis. The study was performed in patients with premature myocardial infarction (n = 129), chronic ischemic heart disease (n = 43), peripheral artery disease (PAD, n = 69), and healthy subjects (n = 225). In all subjects, standard serum biochemistry, UGT1A1 genotypes, total antioxidant status (TAS), and concentrations of various pro- and anti-inflammatory chemokines were determined. Compared to controls, all atherosclerotic groups had significantly lower serum bilirubin and TAS, while having much higher serum high-sensitivity C-reactive protein (hsCRP) and most of the analyzed proinflammatory cytokines (p < 0.05 for all comparisons). Surprisingly, the highest inflammation, and the lowest antioxidant status, together with the lowest serum bilirubin, was observed in PAD patients, and not in premature atherosclerosis. In conclusion, elevated serum bilirubin is positively correlated with TAS, and negatively related to inflammatory markers. Compared to healthy subjects, patients with atherosclerosis have a much higher degree of oxidative stress and inflammation.

Indexed as

atherogenesisatherosclerosisbilirubininflammationoxidative stress

Identifiers

PMID36358491
PMCPMC9686784
OpenAlexW4307630844

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.